Washington State Life Science Research Funding: Non-Profit Organizations
Sponsored Grants, Contracts & Federal Research and Training Awards, 1980-2014
The state of Washington is home to more than thirty life science related non-profit organizations.
These non-profit organizations are fundamental to the research and development of the life science industry
nationally, as well as internationally.
Since 1980, the state's two largest non-profit research institutions, the Fred Hutchinson
Cancer Research Center (FHCRC) and the Pacific Northwest National Laboratory (PNNL)
have together attracted more than $25.6 billion into the state. During FY 2014, the
FHCRC and PNNL received a total of $1.333 billion in grant and contract awards, an
increase of +5.3% or $68.0 million from the $1.265 billion received in FY 2013.
Leading non-profit organizations are included in the following where current and historical
contract award data is available, and total organizational revenue where contract award data
is absent. For those reporting revenue, an average of 65% of the total revenue
was from sponsored grants, contracts & federal research and training awards
(Image: WA Life Science Evolution
- a genealogy poster that illustrates the "technology origins" of nearly 400 life
science firms and non-profit organizations located in the state of Washington).
Allen Institute for Brain Science
Allen Institute for Brain Science --
The Allen Institute for Brain Science is an independent nonprofit medical research organization that was launched
in 2003 with the mission to accelerate the understanding of how the human brain works in health and disease.
The Allen Institute was established with seed funding of $100 million from founder and philanthropist
Paul G. Allen, a Microsoft Corp. co-founder. Mr. Allen committed another $100 million in 2007,
and an additional $300 million in 2012. The most recent funding will support the first four
years of a ten-year plan to expand the Institute's scientific programs, bringing his total commitment
to $500 million to-date. The Allen Institute also receives support from government, foundation and
private funds to further its projects. Since its founding, the Allen Institute has received
more than $14.4 million from the NIH.
Allen Institute for Cell Science
Allen Institute for Cell Science --
Seattle's newest research institute, launched in December 2014 with a $100 million contribution
from Mr. Allen, is the Allen Institute for Cell Science which will serve as a catalyzing
force to integrate diverse technologies and approaches at a large scale in order to
study the cell as an integrated system.
The Allen Institute for Cell Science will be housed in the new Allen Institute
building located in Seattle’s South Lake Union neighborhood. The seven-story, 270,000
square foot building, currently under construction, will also be occupied by the
Allen Institute for Brain Science. The building is scheduled for completion in the
fall of 2015.
Benaroya Research Institute
Benaroya Research Institute at Virginia Mason (BRI) --
As a world-renowned leader in autoimmune disease research, BRI has contributed to major advances
against 80+ autoimmune diseases, such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis,
Crohn’s disease and others. BRI’s collaborative approach accelerates discovery and translates
laboratory breakthroughs to prevent, treat, and ultimately, eliminate these diseases.
Founded in 1956, BRI currently has more than 275 scientific and administrative staff funded by the
NIH, JDRF, The Leona M. and Harry B. Helmsley Charitable Trust and the National Multiple Sclerosis Society.
BRI is one of the few research institutes in the world devoted to discovering causes and cures to eliminate
autoimmune diseases.
In FY 2013, the BRI received total revenue of $47.7 million,
an increase of $4.4 million or 9.2% from the $43.3 million received in FY 2012.
Of this amount, $28.1 million or 59% of the total came from government grants and contracts;
$4.7 million or 10% came from foundation and other grants;
$2.8 million or 6% came from pharmaceutical studies;
$2.8 million or 6% came from contracted research;
$2.4 million or 5% came from donations and endowment revenue;
$.954 million, or 2% was classified as other income, and the remaining $5.7 million
came from Virginia Mason equity transfers. Since 2000, BRI has reported more than
$361.7 million in total revenue
(BRI Annual Report, 2013).
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
(FHCRC) -- The Hutchinson Cancer Center, founded in 1975, is an independent,
nonprofit organization whose mission is to eliminate cancer and other diseases as causes of
human suffering and death.
The Hutch is a pioneer in the development of bone marrow transplantation and its spinoff,
immunotherapy, which harnesses the power of the immune system to kill cancer with minimal side effects.
The Hutch is also home to the nation’s largest and oldest cancer prevention program, which
studies the causes of cancer in human populations and how to prevent it.
The Hutchinson Center, together with its clinical and research partners, the University of
Washington, Seattle Children's and the Seattle Cancer Care Alliance, comprise the
Fred Hutchinson/University of Washington Cancer Consortium. The Consortium is among 40 National
Cancer Institute-designated comprehensive cancer centers nationwide.
The Hutchinson Center also is the Clinical Coordinating Center for the Women’s Health
Initiative, one of the largest studies ever conducted in women’s health.
In FY 2014, the FHCRC reported total revenues of $435.5 million. Of this amount,
$313.7 million or 72% of the total came from research grants and contracts, a decrease of
$15.5 million or 4.7% from the $329.2 million received in FY 2013; the remaining $121.8 million,
or 28% came from contributions, investment and other income.
Since 1980, the FHCRC has received more than $6.4 billion in total grant and contract awards
(FHCRC Annual Report, 2014).
Institute for Systems Biology
Institute for Systems Biology (ISB) -- The
ISB is a world-renowned, non-profit research institute founded in Seattle by Alan Aderem, Ruedi Aebersold, and Leroy Hood,
that is dedicated to the study and application of systems biology.
Founded in 2000, the ISB seeks to unravel the mysteries of biology while identifying strategies for predicting and
preventing diseases, solving energy and environmental issues, and improving K-12 science education. ISB's systems
approach integrates biology, computation and technological development, enabling scientists to analyze all elements
in a biological system rather than one gene or protein at a time. ISB has 9 faculty members and about 200 staff.
In FY 2013, the ISB received total revenue of $44.0 million. Of this amount,
$37.4 million or 85.0% of the total came from grants & contract revenue;
$2.2 million or 5.2% of the total came from contributions;
and the remaining $4.3 million or 9.8% of the total came from investments
and other income. Since it's founding in 2000, the ISB has reported total
revenue of $446.2 million
(ISB Annual Report, 2013).
Pacific Northwest Diabetes Research Institute
Pacific Northwest Diabetes Research
Institute (PNDRI) -- The PNDRI is a nonprofit biomedical research organization
and leader in the global fight against diabetes that was founded by William B.
Hutchinson, Sr., M.D., in 1956. Today, the Institute employs more than 95 scientists,
technical, and professional staff. Its researchers are among the most respected in the
industry—multiple principal scientists are members of the National Academy of
Sciences—and are dedicated to making scientific discoveries that translate
into improved health for all people living with, or at risk of developing, diabetes.
In FY 2013, the PNDRI received total revenue of $8.1 million, an increase of $700,000
or 9.4% compared with the $7.4 million reported in 2012. Of this amount,
$55.9 million or 69.0% of the total came from federal and governmental agency grants
& contract revenue;
$2.0 million or 25.0% of the total came from private grants;
$486,000 or 6.0% of the total came from contributions;
and the remaining $729,000 or 8.0% of the total came from investments
and other income. Since 2003, the PNDRI has reported total
revenue of more than $83.4 million
(PNDRI Annual Report, 2013).
Pacific Northwest National Laboratory
Pacific Northwest National Laboratory (PNNL) -- The PNNL
is one of the U.S. Department of Energy national multiprogram laboratories. Since its creation in 1965,
PNNL has produced dozens of major innovations and advances in the areas of the environment, energy,
health, national security and the basic sciences that support these areas.
In FY 2014, the PNNL received $1.02 billion in grant and contract awards, an increase of
$83.9 million or +8.9% from the $936.1 billion received in FY 2013. It is notable that the current
2014 grant and contract award level is slightly below the $1.059 billion reported in 2009, the highest
award level reported by the PNNL to date. Since 1980, the PNNL has received more than $19.2 billion
in total grant and contract awards. It should be noted that the PNNL grants and contract award data,
like that of the state's universities, is all inclusive and not life science specific,
but is representative of broad federal research funding.
PATH
Program for Appropriate Technology in Health (PATH)
-- PATH is an international nonprofit organization that transforms global health through innovation.
PATH takes an entrepreneurial approach to developing and delivering high-impact, low-cost solutions,
from lifesaving vaccines, drugs, diagnostics, and devices to collaborative programs in more than
70 countries.
PATH, founded in 1977, currently works in the areas of health technologies, maternal and child health, reproductive
health, vaccines and immunization, and emerging and epidemic diseases. Their multidisciplinary staff
includes public health experts with experience in diverse cultural contexts as well as policy and
business strategists skilled in translating promising ideas into products and approaches that
have a lasting impact on health. PATH has offices in 40 cities in 22 countries.
In FY 2013, the PATH received total revenue of $315.1 million, an increase of
$2.3 million or .7% from the $312.8 million received in FY 2012.
Of this amount, $149.7 million or 47.6% of the total came from foundation funding;
$104.5 million or 33.2% of the total came from the U.S. government;
$45.2 million or 14.3% of the total came from the other governments, NGO's, and multilaterals;
and the remaining $15.5 million or 4.9% of the total came from individuals, investments and corporations.
Since 2000, PATH has reported more than $2.3 billion in total revenue.
(PATH Annual Report, 2013).
Seattle BioMed
Seattle BioMed --
Seattle BioMed, founded in 1976, is the largest independent, non-profit research institute in the U.S. focused solely
on the world’s most devastating diseases, including malaria, HIV/AIDS and tuberculosis.
Today, Seattle BioMed is an internationally recognized center for research and training excellence with
connections from Seattle to more than 100 partners and collaborators around the world.
Financial data for FY 2013 were not available at the time of
publication. In FY 2012, Seattle BioMed received total revenue of $46.7 million,
a decrease of $5.0 million or -9.6% from the $51.7 million received in FY 2011.
Of this amount, $32.2 million or 69.0% of the total, came from government grants;
$11.2 million or 24.0% of the total, came from the private grants;
the remaining $3.3 million or 1.6% of the total came from contributions and other income.
Since 2000, Seattle BioMed has reported total revenue exceeding $367.5 million
(Seattle BioMed Annual Report, 2012).
Seattle Children’s Hospital Research Institute
Seattle Children's Hospital
and Regional Medical Center, founded in 1907, occupies a 24-acre site in Seattle's
Laurelhurst neighborhood and serves as the pediatric referral center for
Washington, Alaska, Montana and Idaho.
The Seattle Children’s Hospital Research Institute was founded in 2006
to "treat, prevent and eliminate childhood disease." In the last decade, the Children’s
Research Institute has grown from 40 to 1,200 employees, from 20,000 to 330,000
square feet of space, and from $6 million a year in grants and contracts to nearly
$70 million a year in federal research funding.
In FY 2013, the Children’s Research Institute reported total revenues of $76.1 million,
an increase of $5.6 million or 7.9% from the $70.5 million received in FY 2012.
Of this amount, $51.8 million or 68.1% of the total came from federal research grants
and contracts;
$15.9 million or 20.8% came from private sources; $7.8 million or 10.2% came from
corporate contracts; and the remaining $665,794 or .9% came from other income.
Since its founding in 2006, the Seattle Children’s Research Institute has
received more than
$554.3 million in grant and contract awards
(Seattle Children’s Research Institute Annual Report, 2014).
Back to top
|
